Brief: Orexo, SOBI Agree To Advance Feasibility Study With Amorphox
12/02/2024 07:06
Feb 12 (Reuters) - Orexo AB ORX.ST :
* OREXO AND SOBI AGREE TO ADVANCE FEASIBILITY STUDY WITH
AMORPHOX
Source text for Eikon: ID:nWkr9ynzxr
Further company coverage: ORX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on Orexo AB
See all newsBrief: Orexo Announces Positive Outcome From An In-Vivo Study Of Ox390
Brief: Orexo Announces Positive Outcome From An In-Vivo Study Of Ox390
Brief: Orexo Announces Positive Pre-Clinical Data For Nasal Atipamezole Using Amorphox Technology
Brief: Orexo AB Reports Q1 2026 Net Revenue Of Sek 5.0 Million
Sweden's Orexo Q1 revenue drops, net loss widens